Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Seaman, Michael
Item TypeName
Academic Article HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.
Academic Article Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.
Concept Immunization, Passive
Academic Article Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1.
Academic Article Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.
Academic Article HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.
Academic Article Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency.
Academic Article Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity.
Academic Article Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
Academic Article Early antibody therapy can induce long-lasting immunity to SHIV.
Academic Article Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys.
Academic Article Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.
Academic Article Durable protection against repeated penile exposures to simian-human immunodeficiency virus by broadly neutralizing antibodies.
Academic Article Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques.
Search Criteria
  • Immunization Passive
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.